Evidence map›Paper›PMID 24026680›Full record

ArticleHuman molecular genetics2014

CHD7 and retinoic acid signaling cooperate to regulate neural stem cell and inner ear development in mouse models of CHARGE syndrome.

Joseph A Micucci, Wanda S Layman, Elizabeth A Hurd, Ethan D Sperry, Sophia F Frank, Mark A Durham, Donald L Swiderski, Jennifer M Skidmore, Peter C Scacheri, Yehoash Raphael and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Chromatin remodeling in tissue stem cell fate determination.Cell regeneration (London, England) · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Reprogramming of the epigenome in neurodevelopmental disorders.Critical reviews in biochemistry and molecular biology · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. A New Model for Congenital Vestibular Disorders.Journal of the Association for Research in Otolaryngology : JARO · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Joseph A MicucciDepartment of Biological Chemistry.
Wanda S Layman
Elizabeth A Hurd
Ethan D Sperry
Sophia F Frank
Mark A Durham
Donald L Swiderski
Jennifer M Skidmore
Peter C Scacheri
Yehoash Raphael
Donna M Martin
Pediatrics and Genetics · USUniversity of Michigan–Ann Arbor · USCase Western Reserve University · US

Funding

Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALTSCHULER, RICHARD A · 2002 to 2016
$10.3M
Sensory Mechanisms and Disorders - Administrative SupplementT32DC000011 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Michael Thomas Roberts · 1989 to 2026
$9.5M
Developmental Mechanisms of the Chromodomain Gene Chd7R01DC009410 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARTIN, DONNA M. · 2009 to 2018
$3.7M
The role of gene enhancer elements in colon cancerR01CA160356 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TESAR, PAUL JOSEPH · 2012 to 2023
$3.6M
Genomic studies of CHD7 in CHARGE syndromeR01HD056369 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI SCACHERI, PETER CHRISTOPHER · 2007 to 2011
$1.7M
Role of Chd7 in neural development and maintenanceF31DC010955 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LAYMAN, WANDA SHERRIE · 2010 to 2011
$35k
Characterization of Chd7 in central nervous system neural stem cellsF31DC013227 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MICUCCI, JOSEPH ANTHONY · 2013 to 2013
$31k
NCI NIH HHS R01 CA160356NICHD NIH HHS R01HD056369NIDCD NIH HHS F31 DC010955-01NIDCD NIH HHS F31 DC013227NIDCD NIH HHS F31 DC 013227-01NIDCD NIH HHS P30 DC005188NIDCD NIH HHS P30-DC05188NIDCD NIH HHS R01 DC009410NIDCD NIH HHS T32 DC000011NIDCD NIH HHS T32 DC00011
6 · The paper itself

Abstract

CHARGE syndrome is a multiple congenital anomaly disorder that leads to life-threatening birth defects, such as choanal atresia and cardiac malformations as well as multiple sensory impairments, that affect hearing, vision, olfaction and balance. CHARGE is caused by heterozygous mutations in CHD7, which encodes an ATP-dependent chromatin remodeling enzyme. Identification of the mechanisms underlying neurological and sensory defects in CHARGE is a first step toward developing treatments for CHARGE individuals. Here, we used mouse models of Chd7 deficiency to explore the function of CHD7 in the development of the subventricular zone (SVZ) neural stem cell niche and inner ear, structures that are important for olfactory bulb neurogenesis and hearing and balance, respectively. We found that loss of Chd7 results in cell-autonomous proliferative, neurogenic and self-renewal defects in the perinatal and mature mouse SVZ stem cell niche. Modulation of retinoic acid (RA) signaling prevented in vivo inner ear and in vitro neural stem cell defects caused by Chd7 deficiency. Our findings demonstrate critical, cooperative roles for RA and CHD7 in SVZ neural stem cell function and inner ear development, suggesting that altered RA signaling may be an effective method for treating Chd7 deficiency.

Indexed as

NeurogenesisAnimalsBrainCerebral VentriclesCHARGE SyndromeDisease Models, AnimalDNA-Binding ProteinsEar, InnerHumansMiceMice, KnockoutMutationNeural Stem CellsOlfactory BulbSignal TransductionStem Cell NicheChd7 protein, mouseDNA-Binding ProteinsTretinoin

Identifiers

PMID24026680
PMCPMC3869363
OpenAlexW2160016919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.